Loading clinical trials...
Loading clinical trials...
Whole-exome (WES) or whole-genome sequencing (WGS) are recommended as first- or second-tier molecular tests for patients with developmental disorders (DD), but the clinical utility of WGS continues to...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
NCT04194619 · Vascular Anomaly, Osler Rendu Disease, and more
NCT06019182 · Intellectual Disability, Epilepsy, and more
NCT07029984 · Anorectal Malformations
NCT02879071 · Arteriovenous Malformations
NCT06424392 · Congenital Lung Malformations
KU Leuven
Leuven
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions